Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells

Blood

Volumn 113, Issue 12, 2009, Pages 2706-2714

  Benson Jr , Don M ^a   Yu, Jianhua ^a,b   Beckneil, Brian ^c   Wei, Min ^a   Freud, Aharon G ^c   Ferketich, Amy K ^a   Trotta, Rossana ^a,b   Perrotti, Danilo ^a,b   Briesewitz, Roger ^a,b   Caligiuri, Michael A ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; STEM CELL FACTOR;

ARTICLE; CD34 SELECTION; CELL ACTIVATION; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 63849224072     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-159285     Document Type: Article

References (32)

1. Wu H, Klingmuller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 1995;377:242-246.
2. Lennartsson J, Shivakrupa R, Linnekin D. Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit. J Biol Chem. 2004;279:44544-44553.
3. Duarte RF, Frank DA. SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood. 2000;96:3422-430.
4. Mrózek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996;87:2632-2640.
5. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006;203:1033-1043.
6. Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE, Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med. 1993;178:1079-1084.
7. Fehniger TA, Carson WA, Mrozek E, Caligiuri MA. Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo. Blood. 1997;90:3647-3653.
8. Di Santo JP, Rodewald HR. In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opin Immunol. 1998;10:196-207.
9. Yu TK, Caudell EG, Smid C, Grimm EA. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol. 2000;164:6244-6251.
10. Grund EM, Spyropoulos DD, Watson DK, Muise-Helmericks RC. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. J Biol Chem. 2005;280:4772-4778.
11. Kondadasula SV, Varker K, Lesinski GB, et al. Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow cytometric assay. Cancer Immunol Immunother. 2008;57:1137-1149.
12. Di Noto R, Pane F, CameraA, et al. Characterization of two novel cell lines, DERL-2 (CD56+/ CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCR-gammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Leukemia. 2001;15:1641-1649.
13. Trotta R, Parihar R, Yu J, et al. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 2005;105:3011-3018.
14. Becknell B, Trotta R, Yu J, et al. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J Immunol Methods. 2005;296:115-123.
15. Yu J, Wei M, Becknell B, et al. Pro- and anti-inflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity. 2006;24:575-590.
16. Gaffen SL. Signaling domains of the interleukin 2 receptor. Cytokine. 2001;14:63-77.
17. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of the cyclin-D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A. 1998;95:1091-1095.
18. Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, UeharaY. Induction ofp27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene. 1997;15:629-634.
19. Fry DW, Harvey PJ, Keller PR, et al. Specific inhibition of cycline-dependent kinase 4/6 by PD0332991 and associated anti-tumor activity in human tumor xenografts. Mol Cancer Ther. 2004;3:1427-1438.
20. Toogood PL, Harvey PJ, Repine JT, et al. Discovery of a potent and selective inhibitor of cyclin dependent kinase 4/6. J Med Chem. 2005;48: 2388-2406.
21. Boonen GJ, van Oirschot BA, van Diepen A, et al. Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J Biol Chem. 1999;274:34676-34682.
22. White PC, Shore AM, Clement M, et al. Regulation of cyclin D2 and the cyclin 2 promoter by protein kinase A and CREB in lymphocytes. Oncogene. 2006;25:2170-2180.
23. Freud AG, Becknell B, Roychowdhury S, et al. A human CD34(+ ) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 2005;22:295-304.
24. Carson WE III, Halder S, Baiocchi RA, Croce CM, Caligiuri MA. The c-kit ligand suppresses apoptosis of human natural killer cells through upregulation of bcl-2. Proc Natl Acad Sci USA. 1994;91:7553-7557.
25. Hongyo T, Li T, Syaifudin M, et al. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res. 2000;60:2345-2347.
26. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memoryCD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191:771-780.
27. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9:669-676.
28. Langley KE, Bennett LG, Wypych J, et al. Soluble stem cell factor in human serum. Blood. 1993;81:656-660.
29. Munz C, Dao T, Ferlazzo G, de Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural kill cells. Blood. 2005;105:266-273.
30. Caligiuri MA. Human natural killer cells. Blood. 2008;112:461-469.
31. Yu H, Fehniger TA, Fuchshuber P, et al. Flt3 ligand promotes the generation of a distinct CD34(+ ) human natural killer cell progenitor that responds to interleukin-15. Blood. 1998;92:3647-657.
32. Wang T, Alam R, Langley KE, Klimpel GR. Stem cell factor and IL-2 act synergistically in inducing intraepithelial lymphocyte proliferation and cytokine production: upregulation of the IL-2 receptor gamma-chain and signaling via JAK-3. Cell Immunol. 2000;205:62-71.